Edition:
United States

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

446.00SEK
12:00pm EDT
Change (% chg)

-4.60kr (-1.02%)
Prev Close
450.60kr
Open
450.20kr
Day's High
450.20kr
Day's Low
441.80kr
Volume
8,659
Avg. Vol
14,820
52-wk High
613.00kr
52-wk Low
290.00kr

Chart for

About

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi... (more)
No analyst recommendations are available for .

Overall

Beta: 0.57
Market Cap(Mil.): kr5,256.16
Shares Outstanding(Mil.): 11.64
Dividend: --
Yield (%): --

Financials

  PROB.ST Industry Sector
P/E (TTM): 175.53 19.73 38.77
EPS (TTM): 2.57 -- --
ROI: 3.17 10.88 46.42
ROE: 3.18 14.41 54.22

BRIEF-Probi Q1 Net Sales Fall To SEK 119.2 Million

* Q1 OPERATING PROFIT SEK 4.4 MILLION VERSUS SEK 48.7 MILLION YEAR AGO

May 02 2018

BRIEF-Probi: Positive Results Of Probi's Probiotic Supplement

* PROBI ENTERS THE BONE HEALTH AREA - A NEW AREA FOR PROBIOTICS

Apr 11 2018

BRIEF-Probi Signs Long-Term Agreement With Cilag

* HAS SIGNED A LONG-TERM AGREEMENT WITH CILAG, A MEMBER OF THE JOHNSON & JOHNSON FAMILY OF COMPANIES FOR THE DEVELOPMENT OF A PROBIOTIC PRODUCT

Mar 22 2018

BRIEF-Probi: Clinical Trial Confirms Immune Enhancing Impact Of Probi Defendum

* LARGEST CLINICAL TRIAL CONFIRMS THE IMMUNE ENHANCING IMPACT OF PROBI DEFENDUM® AND SHEDS NEW LIGHT ON THE MECHANISM

Feb 06 2018

BRIEF-Probi Signs Agreement For Product Launch In North America

* SIGNED MAJOR AGREEMENT FOR LAUNCH OF FUNCTIONAL FOOD PRODUCT IN NORTH AMERICA

Dec 12 2017

Earnings vs. Estimates